Handelsbanken Fonder’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.91M Buy
35,000
+8,100
+30% +$427K 0.01% 828
2026
Q1
$1.28M Hold
26,900
﹤0.01% 934
2025
Q4
$1.41M Buy
26,900
+3,000
+13% +$180K ﹤0.01% 889
2025
Q3
$1.55M Hold
23,900
﹤0.01% 826
2025
Q2
$1.16M Hold
23,900
﹤0.01% 895
2025
Q1
$813K Sell
23,900
-500
-2% -$21.2K ﹤0.01% 1022
2024
Q4
$960K Sell
24,400
-4,700
-16% -$222K ﹤0.01% 983
2024
Q3
$1.37M Sell
29,100
-71,200
-71% -$3.61M 0.01% 812
2024
Q2
$5.42M Buy
100,300
+83,600
+501% +$4.84M 0.02% 411
2024
Q1
$1.14M Buy
16,700
+1,000
+6% +$71.6K ﹤0.01% 794
2023
Q4
$983K Buy
15,700
+1,700
+12% +$94K ﹤0.01% 807
2023
Q3
$635K Hold
14,000
﹤0.01% 939
2023
Q2
$786K Buy
14,000
+1,500
+12% +$85.1K ﹤0.01% 840
2023
Q1
$565K Hold
12,500
﹤0.01% 950
2022
Q4
$508K Buy
12,500
+2,700
+28% +$143K ﹤0.01% 950
2022
Q3
$640K Hold
9,800
﹤0.01% 832
2022
Q2
$596K Sell
9,800
-300
-3% -$17.6K ﹤0.01% 924
2022
Q1
$634K Hold
10,100
﹤0.01% 1034
2021
Q4
$765K Hold
10,100
﹤0.01% 1054
2021
Q3
$1.13M Sell
10,100
-100
-1% -$12.6K 0.01% 840
2021
Q2
$1.65M Buy
10,200
+1,300
+15% +$158K 0.01% 686
2021
Q1
$1.08M Hold
8,900
0.01% 800
2020
Q4
$1.36M Sell
8,900
-2,400
-21% -$284K 0.01% 703
2020
Q3
$945K Buy
11,300
+5,300
+88% +$470K 0.01% 745
2020
Q2
$441K Buy
+6,000
New +$351K ﹤0.01% 1018

Other funds holding CRSP